Compare Cigna Corp (CI) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Direxion Daily FTSE China Bull 3x Shares trades at $29.2. The key difference: Cigna Corp pays a 2.24% dividend while Direxion Daily FTSE China Bull 3x Shares pays none, and Cigna Corp is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.
| CI | YINN | |
|---|---|---|
Market Cap | $73.56B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $311.00 | $56.62 |
52-Week Low | $244.41 | $21.45 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
YINN (Direxion Daily FTSE China Bull 3x ETF) trades at $31.50, up 1.68% with a bullish technical signal. The ETF tracks Chinese equities, showing strength amid Hang Seng Index outperformance versus Asian peers. Moving averages signal bullish momentum while oscillators remain neutral. Recent news highlights China's AI investment plans and export growth, though regulatory tensions with the US persist.
Outlook remains cautiously optimistic given China's tech focus and infrastructure spending, but leveraged structure amplifies risks. Key risks include US-China trade tensions and China's economic stabilization efforts. Investors should weigh the ETF's 3x leverage against China's growth trajectory and regulatory environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
